Antimicrobial therapeutics delivery systems based on biodegradable polylactide/polylactide-co-glycolide particles

被引:0
|
作者
Robin Kumar
Divya Jha
Amulya K. Panda
机构
[1] National Institute of Immunology,Product Development Cell
来源
Environmental Chemistry Letters | 2019年 / 17卷
关键词
Infectious diseases; Therapeutic agents; Biodegradable polymer; Polymeric particle; Delivery system;
D O I
暂无
中图分类号
学科分类号
摘要
Infectious diseases are globally associated with high mortality in spite of the availability of therapeutic agents against most pathogenic microorganisms. This is due to the emergence of new infectious diseases and novel pathogen strategies to evade host defenses. There is thus a need to develop potent therapeutics and techniques for effective delivery of vaccines and drugs. Particles based on poly(lactic acid) and poly(lactic-co-glycolic acid) polymer-based particles are suitable delivery systems due to their biodegradable and biocompatible nature. They can be tailored to display various properties such as sustained release, dose sparing, bioactivity maintenance and targeted delivery. This review focuses on polymeric particle-based delivery systems to develop novel vaccines or drugs. Cellular interactions of particulate systems and the mechanism of action in animal models are also discussed.
引用
收藏
页码:1237 / 1249
页数:12
相关论文
共 50 条
  • [21] A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA
    Singh, Manmohan
    Fang, Jia-Hwa
    Kazzaz, Jina
    Ugozzoli, Mildred
    Chesko, James
    Malyala, Padma
    Dhaliwal, Raj
    Wei, Rebecca
    Hora, Maninder
    O'Hagan, Derek
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 327 (1-2) : 1 - 5
  • [22] Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods
    Petrus Viitanen
    Esa Suokas
    Pertti Törmälä
    Nureddin Ashammakhi
    Journal of Materials Science: Materials in Medicine, 2006, 17 : 1267 - 1274
  • [23] Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination
    Helson, Rebecca
    Olszewska, Wieslawa
    Singh, Manmohan
    Megede, Jan Zur
    Melero, Jose A.
    Hagan, Derek O'
    Openshaw, Peter J. M.
    VACCINE, 2008, 26 (06) : 753 - 761
  • [24] Effect of Formulation Variables on Preparation of Celecoxib Loaded Polylactide-Co-Glycolide Nanoparticles
    Cooper, Dustin L.
    Harirforoosh, Sam
    PLOS ONE, 2014, 9 (12):
  • [25] Swelling of Poly(DL-lactide) and polylactide-co-glycolide in humid environments
    Sharp, JS
    Forrest, JA
    Jones, RAL
    MACROMOLECULES, 2001, 34 (25) : 8752 - 8760
  • [26] Structural and functional characterization of proteins adsorbed on hydrophilized polylactide-co-glycolide microfibers
    Vasita, Rajesh
    Katti, Dhirendra S.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 61 - 71
  • [27] Polylactide-co-glycolide nanoparticles of antitubercular drugs: formulation, characterization and biodistribution studies
    Chawla, Ruchi
    Solanki, Harshendra S.
    Kheruka, Subhash Chand
    Gambhir, Sanjay
    Dube, Veeresh
    Aggarwal, Lalit M.
    Mishra, Brahmeshwar
    THERAPEUTIC DELIVERY, 2014, 5 (12) : 1247 - 1259
  • [28] Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer
    Xie, LX
    Shi, WY
    Wang, ZY
    Bei, JZ
    Wang, SG
    CORNEA, 2001, 20 (07) : 748 - 752
  • [29] Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods
    Viitanen, Petrus
    Suokas, Esa
    Tormala, Pertti
    Ashammakhi, Nureddin
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2006, 17 (12) : 1267 - 1274
  • [30] Clinical study of guided bone regeneration with resorbable polylactide-co-glycolide acid membrane
    Kawasaki, Takako
    Ohba, Seigo
    Nakatani, Yuya
    Asahina, Izumi
    ODONTOLOGY, 2018, 106 (03) : 334 - 339